Title

Amegakaryocytic Thrombocytopenia

Department

Internal Medicine

Document Type

Book Chapter

Publication Title

StatPearls [Internet]

Abstract

Amegakaryocytic thrombocytopenia is a severe form of thrombocytopenia with reduced or absent megakaryocytes in the bone marrow. It can be congenital or acquired. There is an eventual progression to impairment in the production of all three cell lines. This activity reviews the evaluation and management of amegakaryocytic thrombocytopenia and explains the interprofessional team's role in evaluating and treating patients with this condition.

Objectives:

  • Describe the etiology of amegakaryocytic thrombocytopenia.
  • Summarize the epidemiology of amegakaryocytic thrombocytopenia.
  • Review pathophysiology of amegakaryocytic thrombocytopenia.
  • Outline some interprofessional team strategies that the healthcare team can use to improve outcomes in patients with lipoid proteinosis.

Publication Date

2021

Share

COinS